The short version of WADA fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
One such study found that administration of DSIP to humans as an adjunct to isoflurane anaesthesia actually increased the heart rate and reduced the depth of anaesthesia instead of deepening it as expected. Low plasma concentrations of DSIP have been found in patients with Cushing's syndrome. In Alzheimer's patients levels of DSIP have been found to be slightly elevated, though this is unlikely to be causal. A preparation of DSIP, Deltaran, has been used to correct central nervous system function in children after antiblastic therapy. Ten children aged 3–16 years were given a ten-day course of Deltaran and their bioelectric activity recorded. It was found that the chemotherapy-induced impairment in the bioelectrical activity of 9 out of the 10 children was reduced by administration of DSIP. DSIP can act antagonistically on opiate receptors to significantly inhibit the development of opioid and alcohol dependence and is currently being used in clinical trials to treat withdrawal syndrome. In one such trial it was reported that in 97% of opiate-dependent and 87% of alcohol-dependent patients the symptoms were alleviated by DSIP administration. In some studies administration of DSIP has alleviated narcolepsy and normalized disturbed sleeping patterns. Safety and possible side-effects of long-term DSIP use haven't been established in clinical research studies.
Cyclopia, the honeybush, or heuningbos in Afrikaans, is a genus of some 20 species of flowering plants in the legume family Fabaceae, subfamily Faboideae. Species of the genus are native to the southern and southwestern Cape Provinces of South Africa. Its description was published by the French botanist Étienne Pierre Ventenat in 1808. The name Ibbetsonia, published two years later, is regarded as a synonym of this genus; John Sims had commemorated the physiologist Agnes Ibbetson with this name.
A mammary gland is an exocrine gland that produces milk in mammals, including humans. Mammals get their name from the Latin word mamma, "breast". The mammary glands are arranged in organs such as the breasts in primates (for example, humans and chimpanzees), the udder in ruminants (for example, cows, goats, sheep, and deer), and the dugs of other animals (for example, dogs, cats, rabbits and pigs) to feed young offspring. Lactorrhea, the occasional production of milk by the glands, can occur in any mammal, but in most mammals, lactation, the production of enough milk for nursing, occurs only in phenotypic females who have gestated in recent months or years. It is directed by hormonal guidance from sex steroids. In a few mammalian species, male lactation can occur. With humans, male lactation can occur only under specific circumstances. Mammals are divided into 3 groups: monotremes, metatherians, and eutherians. In the case of monotremes, their mammary glands are modified sebaceous glands and without nipples. Concerning most metatherians and eutherians, only females have functional mammary glands, with the exception of some bat species. Their mammary glands can be termed as breasts or udders. In the case of breasts, each mammary gland has its own nipple (e.g., human mammary glands). In the case of udders, pairs of mammary glands comprise a single mass, with more than one nipple (or teat) hanging from it.
Sources: en.wikipedia.org
With access to crystal structures, some scientists have tried to model the structures of other mutants. For example, in German ancestry, where enzymopathy due to G6PD deficiency is rare, mutation sites on G6PD have been shown to lie near the NADP+ binding site, the G6P binding site, and near the interface between the two monomers. Thus, mutations in these critical areas are possible without completely disrupting the function of G6PD. In fact, it has been shown that most disease causing mutations of G6PD occur near the NADP+ structural site.
The beta sheet (β-sheet, also β-pleated sheet) is a common motif of the regular protein secondary structure. Beta sheets consist of beta strands (β-strands) connected laterally by at least two or three backbone hydrogen bonds, forming a generally twisted, pleated sheet. A β-strand is a stretch of polypeptide chain typically 3 to 10 amino acids long with backbone in an extended conformation. The supramolecular association of β-sheets has been implicated in the formation of the fibrils and protein aggregates observed in amyloidosis, Alzheimer's disease and other proteinopathies.
Records of slavery in Ancient Greece begin with Mycenaean Greece. Classical Athens had the largest slave population, with as many as 80,000 in the 6th and 5th centuries BC. As the Roman Republic expanded outward, entire populations were enslaved, across Europe and the Mediterranean. Slaves were used for labour, as well as for amusement (e.g., gladiators and sex slaves). This oppression by an elite minority eventually led to slave revolts (see Roman Servile Wars); the Third Servile War was led by Spartacus. By the late Republican era, slavery had become an economic pillar of Roman wealth, as well as Roman society. It is estimated that 25% or more of the population of Ancient Rome was enslaved, although the actual percentage is debated by scholars and varied from region to region. Slaves represented 15–25% of Italy's population, mostly war captives, especially from Gaul and Epirus. Estimates of the number of slaves in the Roman Empire suggest that the majority were scattered throughout the provinces outside of Italy. Generally, slaves in Italy were indigenous Italians. Foreigners (including both slaves and freedmen) born outside of Italy were estimated to have peaked at 5% of the total in the capital, where their number was largest. Those from outside of Europe were predominantly of Greek descent. Jewish slaves never fully assimilated into Roman society, remaining an identifiable minority. These slaves (especially the foreigners) had higher death rates and lower birth rates than natives and were sometimes subjected to mass expulsions.
Sources: en.wikipedia.org
=== Wilhelmina Fassbinder === Wilhelmina Fassbinder (Georgina Rich) is the ambitious new CFO of Pierpoint, and an early champion of the firm's pivot to ESG. She is frequently at odds with Adler, whose influence she warns Eric not to succumb to. Wilhelmina helps new Pierpoint CEO Tom Wolsey salvage the company's future amid a debt crisis, advocating for an ultimately unsuccessful acquisition by Barclays. After Eric brokers a sale to Al-Mi'raj, a holding company of the Egyptian sovereign wealth fund, at Adler's expense, Wilhelmina retains her title while both Eric and Tom lose their jobs. In series 4, Wilhelmina is now CEO of Al-Mi'raj Pierpoint. The firm has invested in payment processor Tender, which is using Pierpoint's wealth management division as a use case for their new banking app. Wilhelmina agrees to invest a further $1 billion in Tender in the form of a contingent convertible bond after negotiations with CFO Whitney Halberstram. After Tender's stock plummets following rumors of fraud and calls for a new audit, Whitney makes a bid for a hostile takeover of Pierpoint in hopes of complicating regulatory scrutiny, and uses his knowledge that Al-Mi'raj is divesting their ownership of Pierpoint to strong-arm Wilhelmina into allowing him to make an offer at Pierpoint's annual general meeting in New York. However, Wilhelmina later calls Henry and reveals that Whitney never bought a stake in Pierpoint as he previously claimed to Henry, and that she merely used his takeover offer as leverage to sell Pierpoint to Temasek Holdings for a higher price.
The manufacturer recommends a "double pour" serve, which according to Diageo should take two minutes. Guinness has promoted this wait with advertising campaigns such as "good things come to those who wait". The brewer recommends that draught Guinness should be served at 6–7 °C (42.8 °F), while Extra Cold Guinness should be served at 3.5 °C (38.6 °F). Before the 21st century, it was popular to serve Guinness at cellar temperature (about 13 °C) and most drinkers preferred it at room temperature (about 20 °C). According to Esquire magazine, a pint of Guinness should be served in a slightly tulip-shaped pint glass, rather than the taller European tulip or 'Nonic' glass, which contains a ridge approx 3/4 of the way up the glass. To begin the pour, the server holds the glass at a 45° angle below the tap and fills the glass 3/4 full. On the way out of the tap, the beer is forced at high speed through a five-hole disc restrictor plate at the end of the tap, creating friction and forcing the creation of small nitrogen bubbles which form a creamy head. The server brings the glass from 45° angle to a vertical position. After allowing the initial pour to settle, the server pushes the tap handle back and fills the remainder of the glass until the head forms a slight dome over the top of the glass (or "just proud of the rim"). Guinness recommends that, to avoid the bitter taste of the nitrogen foam head, gulps should be taken from the glass rather than sipping the drink. In 2010, Guinness redesigned their pint glass for the first time in a decade.
January 22 The United States leaves the World Health Organization. Trump's Executive Order 14253 is carried out, removing exhibits commemorating the history of slavery in the United States at the President's House. January 23 – The Office of Foreign Assets Control imposes sanctions on British-Palestinian activist Zaher Birawi, alleging that he has ties with Hamas. January 23–26 – A major winter storm and cold wave impact over 30 states and kill at least 85 people, with over 15 states of emergency being declared.
"Genius" – 3:43 "Half-Life" – 3:59 "Start Again" (Gerry Leonard) – 3:55 "On Her Mind" (Duncan Sheik, Mick Jones) – 4:11 "Such Reveries" – 5:00 "On a High" – 3:36 "Magazines" – 3:47 "For You" – 2:11 "Good Morning!" – 4:04 "Memento" – 3:47 "Shine Inside" – 10:19 Note: The American version of the album features the song "Chimera" after "Shine Inside" as part of the final track (6 minutes and 28 seconds into the track).
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.